• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Clinical scores in chronic heart failure: does an ideal score exist?].

作者信息

Fontanive Paolo, Miccoli Mario, Scali Maria Chiara, Simioniuc Anca, Dini Frank L, Marzilli Mario

出版信息

G Ital Cardiol (Rome). 2015 Jan;16(1):21-30. doi: 10.1714/1776.19244.

DOI:10.1714/1776.19244
PMID:25689748
Abstract

Numerous prognostic markers have shown to be predictive of patient outcome in heart failure (HF). The recent guidelines of the European Society of Cardiology for the diagnosis and treatment of acute and chronic HF have identified as many as 57 individual markers in patients with HF, including demographic data, etiology, comorbidities, clinical, radiological, hemodynamic, echocardiographic and biochemical parameters. If more accurate risk stratification is required, several scoring systems have been proposed. This article reviews scoring systems for HF prognostication. Although most of the models include readily available clinical information, usually NYHA functional class, left ventricular ejection fraction (LVEF) and comorbidities, quite a few of them comprise Doppler echocardiographic variables, other than LVEF, and circulating levels of natriuretic peptides. In order to achieve a better prediction of the outcome, an ideal score should be based on a comprehensive Doppler echocardiographic examination, the assessment of circulating biomarkers, and a more objective evaluation of exercise tolerance.

摘要

相似文献

1
[Clinical scores in chronic heart failure: does an ideal score exist?].
G Ital Cardiol (Rome). 2015 Jan;16(1):21-30. doi: 10.1714/1776.19244.
2
Comparison among different multiparametric scores for risk stratification in heart failure patients with reduced ejection fraction.比较不同的多参数评分在射血分数降低的心力衰竭患者中的风险分层。
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):12-18. doi: 10.1177/2047487320962990.
3
Multiparametric risk stratification in patients with mild to moderate chronic heart failure.轻度至中度慢性心力衰竭患者的多参数风险分层
J Card Fail. 2007 Aug;13(6):445-51. doi: 10.1016/j.cardfail.2007.03.003.
4
Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.N末端B型利钠肽原(NT-proBNP)在预测心力衰竭患者低功能状态、射血分数降低及心血管事件方面的临界值。
Cardiol J. 2009;16(1):43-9.
5
[Natriuretic peptides--new diagnostic markers in heart disease].[利钠肽——心脏病的新型诊断标志物]
Herz. 2004 Sep;29(6):609-17. doi: 10.1007/s00059-004-2619-8.
6
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.代谢运动试验数据结合心脏和肾脏指标,MECEKI 评分:心力衰竭预后的多参数方法。
Int J Cardiol. 2013 Sep 10;167(6):2710-8. doi: 10.1016/j.ijcard.2012.06.113. Epub 2012 Jul 15.
7
Additive prognostic value of subjective assessment with respect to clinical cardiological data in patients with chronic heart failure.慢性心力衰竭患者主观评估相对于临床心脏病学数据的附加预后价值。
Eur J Cardiovasc Prev Rehabil. 2011 Dec;18(6):836-42. doi: 10.1177/1741826711398804. Epub 2011 Feb 28.
8
[Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology].[根据欧洲心脏病学会指南的利钠肽及其在临床实践中的应用]
Przegl Lek. 2014;71(1):33-5.
9
Predictors of prognosis in patients with stable mild to moderate heart failure.稳定型轻至中度心力衰竭患者预后的预测因素
J Card Fail. 2000 Dec;6(4):306-13. doi: 10.1054/jcaf.2000.20558.
10
B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF.门诊心力衰竭患者 B 型利钠肽评估:来自 IMPROVE HF 的见解。
J Cardiovasc Med (Hagerstown). 2012 Jun;13(6):360-7. doi: 10.2459/JCM.0b013e328353128c.